Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3048 results

Sort By:

Oral Dexmedetomidine in Pediatric MRI

Study ID: NCT05619627
Start Date: 2026-04-01
End Date: 2027-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

18

Intervention / Treatment

Dexmedetomidine

General Anesthesia (control group)

Sponsor

Soroush Merchant

Source: clinicaltrials.gov

Share:
Add to list

Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation

Study ID: NCT07389941
Start Date: 2026-10
End Date: 2029-04
Study Type

Interventional

Study Phase

Phase4

No. of Participants

240

Intervention / Treatment

Semaglutide (SEMA)

Sponsor

University of Luebeck

Source: clinicaltrials.gov

Share:
Add to list

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Study ID: NCT07389278
Start Date: 2026-03-09
End Date: 2035-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

97

Intervention / Treatment

ADI-PEG 20 (pegylated Arginine deiminase)

Temozolomide (TMZ)

Standard of Care Radiation Therapy (RT)

Sponsor

Sabine Mueller, MD, PhD

Source: clinicaltrials.gov

Share:
Add to list

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

Study ID: NCT07029776
Start Date: 2026-07-01
End Date: 2032-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

teclistamab+daratumumab followed by talquetamab+daratumumab followed by duration treatment with daratumumab and lenalidomide extended/maintenance

melphalan (MEL)-based hematopietic stem cell transplantation (HSCT) followed by drug therapy

Sponsor

University of Arkansas

Source: clinicaltrials.gov

Share:
Add to list

Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease

Study ID: NCT06786260
Start Date: 2026-05
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Interventional Diet

Sponsor

Loma Linda University

Source: clinicaltrials.gov

Share:
Add to list

A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies

Study ID: NCT06906380
Start Date: 2026-03-15
End Date: 2040-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

49

Intervention / Treatment

Non interventional study

Sponsor

ARCE Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

1. SAFE-AI ONCO-TRACK: Multimodal GenAI for Early Detection of Minimal Residual Disease and Recurrence in Gastrointestinal Oncology

Study ID: NCT07189520
Start Date: 2026-06-01
End Date: 2030-06-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

700

Intervention / Treatment

Artificial Intelligence

Sponsor

Polytechnic University of Marche

Source: clinicaltrials.gov

Share:
Add to list

Real-time Engagement for Learning to Effectively Control Type 2 Diabetes

Study ID: NCT06375460
Start Date: 2026-04
End Date: 2029-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Focused App Prompt

No App Prompt

Outreach for Missing Data

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list

Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome

Study ID: NCT07247162
Start Date: 2026-08
End Date: 2028-07
Study Type

Interventional

Study Phase

Phase4

No. of Participants

63

Intervention / Treatment

Osilodrostat

Placebo

Sponsor

RECORDATI GROUP

Source: clinicaltrials.gov

Share:
Add to list

Diagnostic Utility of Musculoskeletal Ultrasound in Early Postoperative Evaluation of Posttraumatic Repaired Hand Tendons.

Study ID: NCT07238517
Start Date: 2026-07-01
End Date: 2027-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

MSK US

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list